Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder

Thomas Spencer, John H. Heiligenstein, Joseph Biederman, Douglas E. Faries, Christopher J. Kratochvil, C. Keith Conners, William Z. Potter

Research output: Contribution to journalArticlepeer-review

278 Scopus citations

Fingerprint Dive into the research topics of 'Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences